Unanswered questions in cardiovascular risk assessment

Sponsored by Amgen Australia Pty Ltd

Cardiovascular risk assessment is becoming increasingly important in an era of personalised therapy. In this short podcast, Professor Steve Nissen – in conversation with Professor Stephen Nicholls and Professor Sophia Zoungas – explains what is needed to advance the concept of polygenic risk and make it clinically-useful. They also discuss how incentives could bolster the ...

Already a member?

Login to keep reading.

© 2021 the limbic